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ŹCRISPR/Cas9 induces random deletions in the target region of GABRR2 gene. 
ŹBoth big and small indels can lead to unexpected high probability of exon 
truncation/skipping and exon recruitment.  
ŹIt is the first observation of exon recruitment by CRISPR/Cas9-mediated GABRR2 
gene editing.  
Keywords: CRISPR-Cas9; GABRR2; RGC-5; Exon skipping; Exon recruitment 
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Introduction 
CRISPR/Cas9 is a powerful gene-editing system for efficient genome manipulations 
by using single-guide RNA (sgRNA) that targets the complementary sequence to 
generate double-strand DNA breaks[1-3]. sgRNA and nuclease Cas9 form a nuclease 
complex that hybridizes with genomic DNA containing a NGG protospacer adjacent 
motif (PAM). This system has increased the accessibility of gene editing by greatly 
simplifying the design of editing reagents. Repair of the DNA damage often 
introduces small deletions or insertions that disrupt the target gene and thereby knock 
out its function. CRISPR/Cas9 has been widely used to generate cell and animal lines 
with specific gene function being disrupted or knockout[4-8]. Applying the genome 
surgery to study gene function and to correct disease-associated genetic mutations 
highlights therapeutic applications in curing genetic disorders. 
Exon skipping is a consequence of RNA splicing cause cells to ｗskipｘ over faulty 
or misaligned sections of genetic code, leading to a truncated but still functional 
protein despite the genetic mutation. CRISPR/Cas9-based genome editing can induce 
mutations in genome that has high probability to cause exon truncation, deletion or 
splicing. The accidents that mutations induced exon skipping were usually in the 
cases of the insertion of a large gene cassette or several nucleotides within exon[7,9-
11]. Exon skipping caused by deletion mutations was seldom reported [12]. Screening 
mutations in diploid cells is difficult because of two copies of chromosome. It is an 
important task for determining genotypes in diploid cells, systematically analyzing the 
mutations in two alleles and detecting the real mRNA isoforms in diploid cells 
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subjected to CRISPR/Cas9 editing before using these diploid cells in gene function 
research.  
Retinal ganglion cell (RGC) is a type of neuron located near the inner surface of the 
retina, RGC degeneration is the leading cause of irreversible blindness worldwide. 
GABRR2 is a member of the rho subunit family which forms ligand-gated chloride 
channel on retinal ganglion cell membrane, and it has a significant impact on visual 
information processed by the retina to the brain. In this study, we applied 
CRISPR/Cas9 to edit the GABRR2 gene in mouse retinal ganglion cells (RGC-5) to 
study what exactly happened in two alleles and what real mRNA isoforms formed in 
diploid cells subjected to CRISPR/Cas9 editing. A single sgRNA was employed to 
generate double-strand DNA breaks in the target locus. We used PCR sequencing for 
single clone validation of CRISPR/Cas9-mediated genomic editing in diploid cells. 
The indels and the corresponding effects at the target locus were further studied at 
genomic and RNA levels. Our results show that CRISPR/Cas9 induces random 
deletions in the target region, and both big and small indels can lead to unexpected 
high probability of exon truncation/skipping and exon recruitment phenomena. It is 
the first observation of exon recruitment by CRISPR/Cas9-mediated gene editing.  
Materials and Methods  
Generation of sgRNA targeting constructs  
GABRR2 protein was encoded by 9 exons with total 1473 base pairs of nucleotides. 
The commercial anti-GABRR2 antibody recognized the peptide encoded by exon4. 
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Thus, the sgRNAs targeting exon5 or exon6 region of the GABRR2 gene will be a 
good choice. Moreover, the sgRNAs targeting the middle region of GABRR2 gene 
will induce the termination of protein translation. In this study, four sgRNAs were 
designed based on the high alignment scores and parameter values of NCBI nuclotide 
BLAST by inputting the latest 12bp guide RNA sequence plus 3bp PAM sequence. 
The 15bp guide sequences which can only match GABRR2 exon5 or exon6 regions 
are selected for the final experiment to exclude the off-target effect of CRISPR/Cas9. 
The sgRNAs were synthesized by Invitrogen (Beijing, China), and the guiding 
sequences and target regions were depicted in Figure. 1A. Oligos of sgRNAs were 
annealed and sub-cloned into BbsI-digested pX330 (addgene#42230) and the 
resulting constructs were confirmed by DNA sequencing. 
T7E1 cleavage  
RGC-5 cells were cultured in DMEM medium (Jinuo Biotech, Hangzhou, Zhejiang, 
China) containing 15% FBS (Gibco, Grand Island, NY, USA) and Penn/Strep solution 
(Jinuo Biotech, Hangzhou, Zhejiang, China). Cells grew in 6-well plates with cell 
density around 40% were transfected with 5Pg of Cas9/sgRNA construct using 
/LSRDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV%H\RWLPH%LRWHFK6KDQJKDL
China). After 72 hours, genomic DNA was isolated, and PCR was performed to 
amplify the genomic sequence spanning exon5 and exon6 of the GABRR2 gene using  
5¶-gcaagtgtggacggttaggagc-3¶ (mEx5-F) and 5¶-cggatggtccacaccctatg-3¶mEx6-R). 
PCR conditions were composed of one initial step of 94°C for 5 minutes, followed by 
35 cycles of 94°C for 30 seconds, 56°C for 30 seconds, and 72°C for 90 seconds, and 
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finally single step of 72°C for 10 minutes. PCR products were analyzed by 
electrophoresis on 1% agarose gels. After purification, the PCR products were 
digested using T7E1 enzyme (NEB, Beijing, China).  
Generation of single cell clones 
After transfected with Cas9/sgRNA-4 expression plasmids as described above, 
individual RGC-5 cells were transferred to wells, firstly in 96-well plates and then 6-
well plates, and grown to confluence. Genomic DNA was isolated from individual 
clones and PCR was performed using mEx5-F/mEx6-R primers as described above. 
For clone validation, the PCR products were used for DNA sequencing. For DNA 
further genotype assay, the PCR products were cloned into pMD19-T vectors and 
sequenced. 
Total RNA extraction and RT-PCR 
Total RNA in each single clone was extracted using RNAiso Plus kit (Takara, 
Beijing, China) and cDNA was synthesized by reverse transcription using Takara 1st 
strand cDNA Kit (Takara, Beijing, China). The GABRR2 cDNA sequence spanning 
from exon3 to exon8 was amplified using ¶-ctgtaggtgtggacgtgcagg-¶(-)DQG¶-
agctgacccagaggtagatgtcc-¶(-R). The primers and their target regions were 
highlighted in Figure. 1B. PCR was performed using Tag polymerase under 
following conditions: 5 minutes at 94Ԩ, 35 cycles of 94Ԩ for 30 seconds, 60Ԩ for 30 
seconds and 72Ԩ for 90 seconds, and finally 72Ԩ for 10 minutes. The PCR products 
were cloned into pMD19-T vectors and sequenced. 
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GABRR2 DNA, cDNA and protein sequence analysis 
The DNA sequence results obtained from TA clones conducted by genomic PCR and 
cDNA PCR were compared with published C57BL/6J mouse chromosome 4 genome 
sequence (NCBI reference sequence: NC_000070.6) and mouse GABRR2 cDNA 
(clone MGC:67750; NCBI reference sequence: BC057957.1) to identify clones with 
deletions, insertions or exon skipping. The GARRR2 amino acid sequence was 
predicted from the cDNA and compared to the NCBI protein sequence 
(NP_032102.2). Sequence analysis was performed with chromas software and 
multiple sequence alignments were performed using DNAMAN software (Lynnon 
software platform). 
Western blot analysis 
Protein lysates from cultured cells were prepared in TBS buffer (100 mM Tirs-Cl, 0.9 
% (w/v) NaCl) with proteinase inhibitors (Beyotime Biotechnology, Shanghai, 
China). Proteins were separated on 10% SDS-PAG and then transferred onto 
nitrocellulose membrane, after washing with TTBS buffer (100 mM Tirs-Cl, 0.9 % 
(w/v) NaCl, 0.1 % (v/v) Tween 20) the membrane was probed with 1:1000 anti-
GABRR2 antibody (ab83223, abcam company, China) or 1:1000 anti-Actin 
antibody(CST 8457). The anti-GABRR2 antibody recognized the peptide 
corresponding to a region within the internal sequence amino acids (144-193) that was 
encoded by exon4 (SNKSMTFDGR LVKKIWVPDV FFVHSKRSFT 
HDTTTDNIML RVFPDGHVLY). 
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Results 
CRISPR/Cas9-mediated editing of GABRR2 gene 
We have designed four different single-guide RNAs targeting exon5 and exon6 of the 
mouse GABRR2 gene. T7 Endonuclease I (T7EI) cleavage assay was used to evaluate 
the efficacy of Cas9/sgRNAs. Cas9-induced breaks will leave a variety of mutations, 
and there will always be some wild type sequence remaining. When we amplify the 
target region, denature and renature the PCR products, there will be mismatches at the 
target site. T7EI endonuclease cleaves double-stranded DNA at positions of 
mismatches. As shown in T7E1 cleavage assay (Figure. 2), two DNA bands were 
detected in sgRNA-1, sgRNA-2 and sgRNA-4, indicating that these sgRNAs edited 
the genomic DNA. We chose to use Cas9/sgRNA-4 in final experiments based on 
T7E1 cleavage data, and this plasmid was transformed into RGC-5 cells to generate 
single clones. 
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Abstract   
CRISPR/Cas9 and its variations provide an efficient tool for targeted genome editing. 
CRISPR/Cas9-based genome editing can induce mutations in genome that has high 
probability to cause exon truncation or deletion. However, screening mutations in 
diploid cells is difficult because of two copies of chromosome. It is an important task 
for determining genotypes in diploid cells subjected to editing before using these cells 
in gene function study. In this study, we applied CRISPR/Cas9 to edit the GABRR2 
gene in mouse retinal ganglion cells to study what exactly happened in two alleles and 
what real mRNA isoforms formed in diploid cells. A single sgRNA was employed to 
generate double-strand DNA breaks. PCR sequencing was used for single clone 
validation in diploid cells subjected to editing. The indels and the corresponding 
effects at the target locus were further studied at genomic and RNA levels. We 
observed that CRISPR/Cas9 induces random deletions in the target region of 
GABRR2 gene, and both big and small indels can lead to unexpected high probability 
of exon truncation/skipping. In addition, random deletions in genomic region 
UHFUXLWHGLQWURQVWRJHQHUDWHQHZ³H[RQ´,WLVWKHILUVWREVHUYDWLRQRf exon 
recruitment by CRISPR/Cas9-mediated GABRR2 gene editing. The observations may 
offer a reference for the future gene splicing study.  
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We obtained 10 single cell clones by the limiting dilution cloning method. The 
genomic DNA was purified from individual clones, and the genomic region spanning 
exon5 and exon6 of the GABRR2 gene was amplified using PCR. As illustrated in 
Figure. 3A, a 750-bp PCR band was detected from clones 1, 2, 5, 7-10, while there 
were two bands from clones 3, 4 and 6.  
For clone validation, single-band PCR products were purified and directly sequenced. 
Sequence analysis with chromas software (Figure. 3B) shows sequence disruptions 
around the sgRNA target region in clones 1, 2, 7, 9 and 10, indicating that an unequal 
genome editing occurred in two alleles in these clones. For the clones 3, 4 and 6, both 
DNA bands were purified separately and sequenced. The data suggest that these 
alleles were subjected to unequal genomic editing, with single sgRNA inducing 
deletions of 200bp to 400 bp in one allele. The sequences from clones 5 and 8 were 
not disrupted. The sequence results reveal that clone 8 is wild-type. However, clone 5 
contained a deletion of 56bp in the target region in both alleles.   
Genomic DNA and mRNA sequence analysis of individual clones 
The GABRR2 gene resides on chromosome 4. Since RGC-5 cells are diploid and 
exhibit two copies of chromosome 4, above easy validation can only prove which 
single clone underwent genome editing. To further understand what exactly happened in 
two alleles, PCR products spanning exon5 and cxon6 of the GABRR2 gene in all 
clones were subcloned into pMD19-T vector and sequenced. To analyze the effects at 
the mRNA level, complimentary DNA (cDNA) was prepared from total RNA in all 
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clones and used as a PCR template to determine the coding region spanning from 
exon3 to exon8 of the GABRR2 gene. The changes in the genomic DNA and cDNA 
are demonstrated in Figure 4.  
Clone 1 exhibited unequal modifications (Figure. 4A). Deletions of 2bp and 4bp in 
the targeting sequence were detected in two alleles, respectively. Analysis of cDNA 
sequence reveals that 2bp and 4bp deletions corresponding to the genomic defection 
occurred in exon5 and exon7 was spliced out.  
Clone 2 had a deletion of 2bp in the targeting sequence in one allele and a large 
deletion of 79bp in another allele. The latter deletion was composed of 60bp in the 
last part of exon5 and 19bp in the initial part of intron5 (Figure. 4B). When the 
GABRR2 cDNA sequence was examined, the corresponding 2bp deletion in exon5 
was observed but no other deletion or mutation was detected in this variant. 
Interestingly, the GABRR2 mRNA showed splicing of exon5 and also contained an 
insertion from the initial 18bp sequence of intron7 inWRH[RQWRIRUPDQHZ³H[RQ´ 
In clone 3, deletions of 318bp in one allele and 34bp in another in the target region 
were observed (Figure. 4C), corresponding to the two apparent DNA bands (Figure. 
3A). The 318bp deletion consists of the last 71bp sequence of exon5, the whole 
intron5 (186bp long) and the first 61bp of exon6. This genotype was reflected in the 
mature mRNA with 71bp in exon5 and 61bp in exon6 being missing. In the 34bp 
deletion, the missing part was composed of the last 27bp part of exon5 and 7bp 
sequence (GTAATGA) of intron5. Deletion of these parts altered the excision of 
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intron5. Consistently, the last 27bp of exon5 was absent in the mature mRNA. 
)XUWKHUPRUHWKHUHPDLQLQJESLQLQWURQEHFDPHDQHZ³H[RQ´DQGZDV
incorporated into the mature mRNA between exon5 and exon6.  
Clone 4 contained deletions of 18bp and 487bp surrounding the target region in two 
alleles, respectively (Figure. 4D). For the larger deletion, the last 226bp of intron4, 
the whole exon5 (83bp long) and the first 178bp of intron5 were deleted. While in the 
short deletion, the last 18bp of exon5 was removed. At the mRNA level, both exon5 
and exon6 were spliced out in the mature mRNA. In addition, another mRNA isoform 
was discovered, in which part of exon5 (the last 62bp) and the whole exon6 was lost, 
DQGDQHZ³H[RQ´RIESORQJDSSHDUHGDQGOLQNHGWRH[RQThis 150bp new 
³H[RQ´ZDVRULJLQDOO\IURPLQWURQZLWKWKHLQQHUVLWHIURPESWRES 
Clone 5 contained a deletion of 56bp around the target region in two alleles (Figure. 
4E). The 56bp deletion was composed of 34bp in the last part of exon5 and 22bp in 
the initial part of intron5. Both exon5 and exon6 were spliced out in the mature 
mRNA. 
In clone 6, deletions of 60bp and 257bp in the target region were observed (Figure. 
5A), consistent with the two apparent PCR products (Figure.3A). The 60bp deletion 
resulted in loss of the last 30bp of exon5 and 30bp of intron5. Such a deletion gave 
rise to splicing out of exon5 and exon7 in the mature mRNA. The 257bp deletion in 
the second allele removed the last 152bp of intron4, the whole exon5 (83bp) and the 
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first 22bp of intron5, leading to generation of a new mRNA isoform without exon4, 
exon5, exon6 and exon7.  
Clone 7 exhibited unequal modifications within the targeting area with deletions of 
1bp in one allele and 7bp in the second allele (Figure. 5B). At the mRNA level, one 
splicing isoform resulting from the 7bp deletion in exon5 and, in this isoform, exon7 
was spliced out. We also obtained a different splice isoform without exon5, exon6 and 
exon7.  
Deletions of 1bp and 2bp within the targeting sequence were detected in clone 9 
(Figure. 5D). The 1bp deletion in exon5 corresponding to the genomic defection was 
observed in the mature mRNA, in which exon7 was spliced out. While the 2bp 
deletion corresponding to the genomic defection was not observed in the mRNA, an 
isoform with deletion of the last 21bp of exon5 and the whole exon7 was detected.  
Deletions of 2bp and 4bp within the targeting sequence were seen in clone 10 
(Figure.5E)7KHESGHOHWLRQJHQHUDWHGDQHZ³H[RQ´LQWKHPDWXUHP51$
resulting from insertion of 18bp originally located in intron7 immediately after exon7. 
The exon7 was spliced out in the mature mRNA as a result of the 4bp deletion. 
Protein expression pattern analysis 
To confirm the effects of CRISPR/Cas9 editing on the GABRR2 protein expression, 
western blotting was performed by using anti-GABRR2 antibody recognizing the 
peptide sequence (144-193) that was encoded by exon4. This is the only anti-
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GABRR2 antibody tagged epitope in the current market. Unfortunately, this 
commercial antibody is not specific for GABRR2 (data not shown). 
CRISPR/Cas9-mediated exon splicing or frameshifts were therefore predicted by 
translating cDNA sequences using DNAMAN software. The wild-type GABRR2 
protein is 490 amino acid residues long with a molecular weight of 57 kDa. As shown 
in Figure 6, both exon splicing and deletion resulting from CRISPR/Cas9-mediated 
gene editing could generate premature translation of the GABRR2 protein. Different 
mRNA deletion or splicing isoforms could produce proteins with various lengths 
ranging from 355 amino acids (clone 1), 332 amino acids (clone 5) and 320 amino 
acids (clone 4) to 123 amino acids (clone 6).  
Discussion 
CRISPR/Cas9 and its variations provide an efficient and convenient tool for targeted 
genome editing in mammalian cells, rodent embryo, zebrafish, drosophila, plants and 
bacteria[1,4,7,8,13,14]. These DNA editing strategies have been widely used for gene 
knock-out and knock-in, mutation, targeted correction and even chromosome 
elimination and inversion[15-19], highlighting promising therapeutic applications. 
DNA damage and mutation have also been shown to regulate exon skipping[20,21]. 
The accidents that CRISPR/Cas9-mediated mutations induced exon skipping were 
reported usually in the cases of the insertion mutations. An early study reported exon 
skipping due to insertions of a large gene cassette[10]. An insertion of seven 
nucleotides in exon3 of pycr1a gene resulted in exon skipping in zebrafish[7]. 
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Moreover, Single nucleotide insertion within exon3 of FLOT1 gene induced random 
splicing of several exons in Hela cells[22]. In contrast, the exon skipping accident 
induced by the deletion mutations was rarely reported, a study using pairs of sgRNAs 
to cut whole exon14 out of MET gene in HEK293 cells caused exon14 splicing out in 
matured mRNA corresponding to the genomic defection [21]. In addition, a recent 
study focusing on CRISPR/Cas9-mediated ȕ-catenin gene editing shows small 
deletions or insertions that partially alters exon splicing or unexpected larger 
deletions[12]. Above cases had recently been summarized in a review[11]. In the 
current study, we provide evidence that single sgRNA induced random exon deletions 
in the target region in the GABRR2 gene in RGC-5 cells. A high frequency of such 
exon deletions in the genome causes skipping of one or several exons in the mature 
mRNA.  
The main defect of CRISPR/Cas9 gene editing is the off-target effect. The specificity 
of sgRNA is the key factor controlling the off-target effect. In this study, the latest 
12bp guide RNA sequence plus 3bp PAM sequence were used in BLAST assay. The 
15bp guide sequences which can only match GABRR2 exon5 or exon6 regions are 
selected for the experiment to exclude the off-target effect of CRISPR/Cas9 on 
GABRR2. In the current study, we focused on the effect of genomic editing in exon5 
by analyzing the mRNA sequence from exon3 to exon8. The strategy screening 
several exons upstream and downstream of the targeted exon enables us to obtain 
enough sequence information for analyzing mRNA isoforms induced by 
CRISPR/Cas9. We showed that removal of large DNA fragments in the genome using 
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CRISPR/Cas9 unexpectedly initiated recruitment of adjacent introns to form new 
³H[RQ´LQWKHPDWXUHP51$6XFKH[RQUHFUXLWPHQWZDVGHWHFWHGLQfour clones in 
the current study. Deletions initiated exon recruitment which occurs randomly in any 
intron regions of the genome. For example, in clones 2 and 10, a deletion of 18bp of 
intron7 was incorporated into the mature mRNA. For clone3, deletion of 34bp, 
composed of the last 27bp of exon5 and 7bp of intron5, altered excision of intron5 or 
mRNA editing. Moreover, in clone 4, 150bp sequence within intron6 was recruited 
and incorporated into the mature mRNA. Our results provide evidence on the function 
of intron in genome, intron sequences could be used as a resource for formation of 
new exons. To our knowledge, this is the first observation of such exon recruitment 
by CRISPR/Cas9-PHGLDWHGJHQHHGLWLQJ6XFKQHZ³H[RQ´could be translated to 
form unexpected proteins that are not endogenously expressed by cells and confer 
new functions. Therefore, one should analyze the results from CRISPR/Cas9-
mediated gene editing with caution. 
CRISPR/Cas9 has been exploited to study alternative splicing of the titin gene by 
precisely deleting the MEX5 exon in the murine genome[23]. In our observation, all 
clones analyzed show different genome editing patterns. For example, deletions, as 
small as 1-4bp, have such far-reaching effects on distant exons, and the exon 7 is 
especially vulnerable to indels. A novel exon splicing enhancer or sequence module 
residing around the sgRNA-4 cut site was supposed to be involved into the regulation 
of exon 7 usages. Surprisingly, many of the mutations caused unpredictable splicing 
patterns. In clone 7 and 9, the same 1bp deletion amazingly results in two different 
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splicing defects in two separate clones. It looks like the exon splicing phenomenon 
occurred randomly in the cells. However, no answer can be offer for these questions. 
Further studies are required to provide a better understanding of the exon splicing 
mechanism.  
Conclusions 
PCR sequencing was employed for the validation of gene editing in RGC-5 diploid 
cells, it revealed that CRISPR/Cas9-mediated GABRR2 gene editing can result in 
random exon splicing, exon deletions and exon recruitment. The observations in this 
study may offer a reference for the future gene splicing study and it could also be 
useful for future meta studies.  
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Figure legends 
Figure 1. CRISPR-Cas9-Mediated GABRR2 Gene Editing in Mouse RGC5 cells. 
(A) Schematic illustration of the sgRNA targeting site in the GABRR2 gene. The 
sgRNA guiding sequences are labeled in yellow. Protospacer adjacent motif (PAM) is 
marked in green. Primers for PCR to amplify the GABRR2 genomic sequence 
spanning exon5 and exon6 are marked by red arrow. Exon5 and exon6 are indicated 
in gray halftones. (B) Schematic representation of the primers target sequences in 
exon3 and exon8. These primers were used on cDNA amplification and sequencing. 
Red lines illustrate the locations of E3-F and E8-R primers. Exon3 and exon8 are 
indicated in gray halftones. 
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Figure 2. T7E1 cleavage assay on PCR products from different cell clones 
subjected to Cas9-sgRNA modification. M, DNA markers; 1, wild-type RGC5 cell 
without sgRNA/Cas9 modification; 2, sgRNA-1; 3, sgRNA-2; 4, sgRNA-3; 5, 
sgRNA-4. Arrows indicate the T7E1 cleavage bands resulting from sgRNA-mediated 
editing. 
Figure 3. Validation of GABRR2 gene editing in different RGC-5 cell clones. (A) 
Electrophoresis assay on PCR products amplifying the genomic region spanning 
exon5 and exon6 of the GABRR2 gene in different cell clones. The numbers represent 
the PCR products from the related clones. (B) DNA sequencing of the PCR products 
confirms the status of CRISPR/Cas9 targeted genome region in different clones. 
Clone 8 is wild-type. Deletion of DNA in clone 5 confirmed CRISPR/Cas9-mdiated 
editing in two alleles. The red lines show the sequence disruptions, indicating 
genomic editing in two alleles.  
Figure 4. Schematic illustration and analysis of GABRR2 isoforms in clones 1-5. 
Genomic DNA and cDNA sequences were determined by subcloning of PCR 
products and sequencing.The genomic DNA and cDNA sequencing maps are attached 
behind the schema. The cutting cassette showed the deletions in DNA or cDNA. 
Figure 5. Schematic illustration and analysis of GABRR2 isoforms in clones 6-10. 
Genomic DNA and cDNA were used as PCR templates, TA cloning and DNA 
sequencing were to confirmed the isoforms of GABRR2 in clones 6-10.The 
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sequencing maps are attached behind the schema. The cutting cassette showed the 
deletions in DNA or cDNA. 
Figure 6. GABRR2 protein expression pattern in single cell clones. Different exon 
splicing or deletion isoforms are predicted to generate truncated stop of GABRR2 
proteins by analyzing the RT-PCR products spanning exon3 to exon8 of GABRR2. 
The stop code in each cDNA sequence is marked by red line. The partial cDNA 
sequences and lenth of amino acids are showed in different clones.  
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